Transcriptomics

Dataset Information

0

The RhoJ-BAD Signaling Network: An Achilles Heel for BRAF Mutant Melanomas


ABSTRACT: Genes and pathways that allow cells to cope with oncogene-induced stress represent selective cancer therapeutic targets that remain largely undiscovered. In this study, we identify a RhoJ signaling pathway that is a selective therapeutic target for BRAF mutant cells. RhoJ deletion in BRAF mutant melanocytes modulates the expression of the pro-apoptotic protein BAD as well as genes involved in cellular metabolism, impairing nevus formation, cellular transformation, and metastasis. Short-term treatment of nascent melanoma tumors with PAK inhibitors that block RhoJ signaling halts the growth of BRAF mutant melanoma tumors in vivo and induces apoptosis in melanoma cells in vitro via a BAD-dependent mechanism. As up to 50% of BRAF mutant human melanomas express high levels of RhoJ, these studies nominate the RhoJ-BAD signaling network as a therapeutic vulnerability for fledgling BRAF mutant human tumors.

ORGANISM(S): Mus musculus

PROVIDER: GSE101859 | GEO | 2017/07/26

SECONDARY ACCESSION(S): PRJNA395724

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2017-07-31 | GSE96753 | GEO
2017-07-31 | GSE96902 | GEO
2021-03-29 | PXD014347 | Pride
2022-01-24 | GSE180567 | GEO
2013-08-01 | E-GEOD-46801 | biostudies-arrayexpress
2012-05-01 | E-GEOD-30812 | biostudies-arrayexpress
2020-10-20 | GSE154679 | GEO
2013-08-01 | E-GEOD-46817 | biostudies-arrayexpress
2012-05-02 | GSE30812 | GEO
2014-06-01 | GSE47971 | GEO